SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-18-008730
Filing Date
2018-12-27
Accepted
2018-12-27 12:40:48
Documents
2
Period of Report
2018-12-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1699
2 POWER OF ATTORNEY poa_meyers.htm EX-24.1 9120
  Complete submission text file 0001567619-18-008730.txt   12190
Mailing Address GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY CA 94404
Business Address
Meyers James R (Reporting) CIK: 0001387521 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37587 | Film No.: 181254256

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Issuer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations